These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 28532546)

  • 1. Sensitivity to ALK-Directed Therapy in Osteosarcoma With an Acquired
    Ordulu Z; Giunta P; Hung WT; Hung YP; Simon J; Fintelmann FJ; Lennerz JK; Naxerova K; Cote GM
    JCO Precis Oncol; 2023 Sep; 7():e2300287. PubMed ID: 38096470
    [No Abstract]   [Full Text] [Related]  

  • 2. Multimodality Treatment of Pulmonary Sarcomatoid Carcinoma: A Review of Current State of Art.
    Zhang L; Lin W; Yang Z; Li R; Gao Y; He J
    J Oncol; 2022; 2022():8541157. PubMed ID: 35368903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical Advanced in Early-stage ALK-positive Non-small Cell Lung Cancer Patients].
    Gao Q; Jiang X; Huang C
    Zhongguo Fei Ai Za Zhi; 2017 Feb; 20(2):124-129. PubMed ID: 28228224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anaplastic lymphoma kinase rearrangement in lung cancer: its biological and clinical significance.
    Toyokawa G; Seto T
    Respir Investig; 2014 Nov; 52(6):330-8. PubMed ID: 25453376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A Case Report of Pulmonary Sarcomatoid Carcinoma with ALK Rearrangement].
    Miao Y; Ling L; Zhang X; Huang J
    Zhongguo Fei Ai Za Zhi; 2017 May; 20(5):366-370. PubMed ID: 28532546
    [No Abstract]   [Full Text] [Related]  

  • 6. A Long-Term Spinal Intramedullary Response to Ceritinib in ALK Rearranged Non-Small-Cell Lung Cancer.
    Biya J; Caramella C; Lindsay CR; Planchard D; Besse B
    J Thorac Oncol; 2015 Jun; 10(6):e44-5. PubMed ID: 26001149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive histologic analysis of ALK-rearranged lung carcinomas.
    Yoshida A; Tsuta K; Nakamura H; Kohno T; Takahashi F; Asamura H; Sekine I; Fukayama M; Shibata T; Furuta K; Tsuda H
    Am J Surg Pathol; 2011 Aug; 35(8):1226-34. PubMed ID: 21753699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemistry as a screening tool for ALK rearrangement in NSCLC: evaluation of five different ALK antibody clones and ALK FISH.
    Hutarew G; Hauser-Kronberger C; Strasser F; Llenos IC; Dietze O
    Histopathology; 2014 Sep; 65(3):398-407. PubMed ID: 24612196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anaplastic lymphoma kinase (ALK) gene rearrangement in non-small cell lung cancer (NSCLC): results of a multi-centre ALK-testing.
    V Laffert M; Warth A; Penzel R; Schirmacher P; Jonigk D; Kreipe H; Schildhaus HU; Merkelbach-Bruse S; Büttner R; Reu S; Kerler R; Jung A; Kirchner T; Wölfel C; Petersen I; Rodriguez R; Jochum W; Bartsch H; Fisseler-Eckhoff A; Berg E; Lenze D; Dietel M; Hummel M
    Lung Cancer; 2013 Aug; 81(2):200-6. PubMed ID: 23669200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case records of the Massachusetts General Hospital. Case 21-2011. A 31-year-old man with ALK-positive adenocarcinoma of the lung.
    Shaw AT; Forcione DG; Digumarthy SR; Iafrate AJ
    N Engl J Med; 2011 Jul; 365(2):158-67. PubMed ID: 21751909
    [No Abstract]   [Full Text] [Related]  

  • 11. Pulmonary Sarcomatoid Carcinoma with ALK Rearrangement: Frequency, Clinical-Pathologic Characteristics, and Response to ALK Inhibitor.
    Chen X; Zhang Y; Lu J; Xu C; Liang J; Wang F; Sun W; Fang S; Yuan J; Wang H; Wang H; Liu X; Chen L
    Transl Oncol; 2017 Apr; 10(2):115-120. PubMed ID: 28081478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical data from the real world: efficacy of Crizotinib in Chinese patients with advanced ALK-rearranged non-small cell lung cancer and brain metastases.
    Xing P; Wang S; Hao X; Zhang T; Li J
    Oncotarget; 2016 Dec; 7(51):84666-84674. PubMed ID: 27835868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of pulmonary sarcomatoid carcinoma: analysis of 33 cases.
    Terra SB; Jang JS; Bi L; Kipp BR; Jen J; Yi ES; Boland JM
    Mod Pathol; 2016 Aug; 29(8):824-31. PubMed ID: 27174587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended Survival and Prognostic Factors for Patients With ALK-Rearranged Non-Small-Cell Lung Cancer and Brain Metastasis.
    Johung KL; Yeh N; Desai NB; Williams TM; Lautenschlaeger T; Arvold ND; Ning MS; Attia A; Lovly CM; Goldberg S; Beal K; Yu JB; Kavanagh BD; Chiang VL; Camidge DR; Contessa JN
    J Clin Oncol; 2016 Jan; 34(2):123-9. PubMed ID: 26438117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification.
    Travis WD; Brambilla E; Nicholson AG; Yatabe Y; Austin JHM; Beasley MB; Chirieac LR; Dacic S; Duhig E; Flieder DB; Geisinger K; Hirsch FR; Ishikawa Y; Kerr KM; Noguchi M; Pelosi G; Powell CA; Tsao MS; Wistuba I;
    J Thorac Oncol; 2015 Sep; 10(9):1243-1260. PubMed ID: 26291008
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.